Phase III clinical trial - Pédiatrie Neuroblastomes
HR-NBL2
Pédiatrie Neuroblastomes
Ouvert depuis le: 04.23.2024
Site: Paris
Public cible
Enfant
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Description de l'essai
This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.
Liens utiles
GUDRUN SCHLEIERMACHER
Investigateur principal